Search results for "conversion."

showing 10 items of 695 documents

Symptom-specific amygdala hyperactivity modulates motor control network in conversion disorder

2016

Initial historical accounts as well as recent data suggest that emotion processing is dysfunctional in conversion disorder patients and that this alteration may be the pathomechanistic neurocognitive basis for symptoms in conversion disorder. However, to date evidence of direct interaction of altered negative emotion processing with motor control networks in conversion disorder is still lacking. To specifically study the neural correlates of emotion processing interacting with motor networks we used a task combining emotional and sensorimotor stimuli both separately as well as simultaneously during functional magnetic resonance imaging in a well characterized group of 13 conversion disorder…

MaleEmotionslcsh:RC346-4290302 clinical medicineddc:150Brain Mappingmedicine.diagnostic_testfMRI05 social sciencesMotor CortexPsychophysiological InteractionRegular ArticleMiddle AgedAmygdalaMagnetic Resonance ImagingFacial ExpressionSubthalamic nucleusmedicine.anatomical_structureNeurologylcsh:R858-859.7FemalePsychologyFacial RecognitionAdultCognitive NeuroscienceEmotion processingPsychogenic paresisMotor Activitylcsh:Computer applications to medicine. Medical informaticsAmygdala050105 experimental psychologyYoung Adult03 medical and health sciencesSubthalamic NucleusmedicineHumans0501 psychology and cognitive sciencesRadiology Nuclear Medicine and imagingMotor networkConversion disorderlcsh:Neurology. Diseases of the nervous systemNeural correlates of consciousnessMotor controlmedicine.diseaseConversion DisorderNeurology (clinical)Functional magnetic resonance imagingNeurocognitiveNeuroscience030217 neurology & neurosurgeryNeuroImage: Clinical
researchProduct

Patterns of transmitted HIV drug resistance in Europe vary by risk group

2014

BACKGROUND: In Europe, a continuous programme (SPREAD) has been in place for ten years to study transmission of drug resistant HIV. We analysed time trends of transmitted drug resistance mutations (TDRM) in relation to the risk behaviour reported. METHODS: HIV-1 patients newly diagnosed in 27 countries from 2002 through 2007 were included. Inclusion was representative for risk group and geographical distribution in the participating countries in Europe. Trends over time were calculated by logistic regression. RESULTS: From the 4317 patients included, the majority was men-having-sex-with-men -MSM (2084, 48%), followed by heterosexuals (1501, 35%) and injection drug users (IDU) (355, 8%). MSM…

MaleEpidemiologygenotypeHuman immunodeficiency virus 1HIV InfectionsRNA directed DNA polymerase inhibitorhigh risk patientLogistic regressionSettore MED/42 - Igiene Generale E ApplicataMen who have sex with men0302 clinical medicineImmunodeficiency Virusesmiddle agedstatistics and numerical data10. No inequalitySubstance Abuse Intravenous0303 health sciencesadulttransmissionvirus diseasesvirus transmissionhighly active antiretroviral therapyHIV immunopathogenesis3. Good healthMedical MicrobiologyViral Pathogenshigh risk behaviorMedicineScience & Technology - Other TopicsPOPULATIONShealth programanti human immunodeficiency virus agentUSERSmedicine.medical_specialtyScienceSexual BehaviorImmunologySexually Transmitted Diseasesintravenous drug abuse-Microbiology03 medical and health sciencesAntibiotic resistanceSDG 3 - Good Health and Well-beingHuman immunodeficiency virus infectionproteinase inhibitorHumansProtease InhibitorshumanHeterosexualityMicrobial PathogensseroconversionMedicine and health sciencesScience & TechnologyGenitourinary InfectionsMUTATIONSVirologymajor clinical studyLogistic Modelstransmitted drug resistance mutationHeterosexualityHIV-1Viral Diseases:Medical sciences: 700::Basic medical dental and veterinary sciences: 710::Medical immunology: 716 [VDP]drug responsemen who have sex with menDrug resistanceClinical immunologygeographyAPPEARANCEmale homosexualityMedizinische Fakultätimmune system diseasesEpidemiologyINFECTIONMedicine and Health Sciencessubstance abuse030212 general & internal medicineriskMultidisciplinaryACTIVE ANTIRETROVIRAL THERAPYTransmission (medicine)virus mutationQRarticleObstetrics and GynecologyHIV diagnosis and managementMiddle AgedvirologyMultidisciplinary SciencesEuropeInfectious Diseasesfemale:Medisinske fag: 700::Basale medisinske odontologiske og veterinærmedisinske fag: 710::Medisinsk immunologi: 716 [VDP]Reverse Transcriptase InhibitorsHIV clinical manifestationsFemaleepidemiologyblood samplingHIV drug resistanceResearch ArticleAdultRiskrisk-groupAnti-HIV AgentsUrologyprevalenceInfectious Disease Epidemiologysexual behaviorRisk-Takingmaleantiviral resistanceInternal medicineDrug Resistance Viralmedicinecontrolled studyddc:610Homosexuality Male030304 developmental biologydrug resistanceBiology and life sciencesbusiness.industrystatistical modelHIVCD4 lymphocyte countheterosexualitynonnucleoside reverse transcriptase inhibitorHuman immunodeficiency virus 1 infectionDiagnostic medicineINDIVIDUALSdrug effectsWomen's Healthbusinesstrend study
researchProduct

Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?

2009

Background/Aim: Patients with an occult hepatitis B virus (HBV) infection undergoing deep immunosuppression are potentially at risk of HBV reactivation. In order to assess whether a polymerase chain reaction (PCR) assay for HBV DNA in serum could be used to predict the reactivation of an occult HBV infection, we performed a retrospective study in a cohort of Sicilian patients with oncohaematological diseases. Methods: We studied by a highly sensitive ad hoc nested PCR for serum HBV DNA 75 HBsAg-negative oncohaematological patients requiring chemotherapy. Results: Thirty-three patients (44%) were HBV seronegative (anti-HBc and anti-HBs negative) and 42 patients (56%) were HBV seropositive (a…

MaleHBsAgHepatitis B virusHepatitis C virusAntineoplastic AgentsComorbiditymedicine.disease_causePolymerase Chain ReactionSerologyCohort StudiesBlood serumHepatitis B ChronicPredictive Value of TestsRecurrenceRisk FactorsmedicineHumansSeroconversionRetrospective StudiesHepatitis B virusHepatologybusiness.industryvirus diseasesHepatitis BMiddle Agedmedicine.diseasedigestive system diseasesItalyHematologic NeoplasmsImmunologyDNA ViralFemaleVirus ActivationbusinessNested polymerase chain reactionLiver international : official journal of the International Association for the Study of the Liver
researchProduct

Hepatitis B Virus DNA in Liver Tissue of Chronic HBsAg Carriers in Childhood and Its Relationship to Other Viral Markers

1992

The aim of the study was to examine the state of hepatitis B virus (HBV) DNA in liver tissue of 103 children with chronic hepatitis B aged 0.5-18 years to detect free and integrated viral sequences by Southern blot hybridization. HBV DNA was found in 74 patients. Seventy-two were seropositive for hepatitis B e antigen (HBeAg) and two had anti-HBe antibodies. Integrated sequences could be demonstrated in two children. One of them had only integrated HBV DNA and was anti-HBe seropositive. The other one presented both free and integrated viral sequences and developed seroconversion from HBeAg to anti-HBe 5 months after biopsy. In 29 hepatitis B surface antigen (HBsAg) carriers, no HBV DNA coul…

MaleHepatitis B virusHBsAgAdolescentHepatitis B virus DNA polymerasemedicine.disease_causeHumansMedicineSeroconversionChildSouthern blotHepatitis B virusHepatitis B Surface Antigensbusiness.industryLiver cellGastroenterologyInfantvirus diseasesHepatitis BVirologydigestive system diseasesBlotting SouthernLiverHBeAgChild PreschoolCarrier StateChronic DiseaseDNA ViralPediatrics Perinatology and Child HealthImmunologyFemalebusinessViral loadJournal of Pediatric Gastroenterology and Nutrition
researchProduct

Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infecti…

1994

A 48-year-old male patient was admitted with acquired immunodeficiency syndrome (stage III, Centers for Disease Control 1993) and viremic hepatitis B. Blood CD4 count was 15/microliters. Discontinuation of prednisolone, previously prescribed by the patient's family practitioner because of elevated liver enzymes, resulted in severe hepatitis (alanine aminotransferase > 300U/l). Administration of interferon-alpha (9 x 10(6) U s.c. 3 x weekly) was initiated. Serum markers of viral replication disappeared, and aminotransferase levels returned to normal within a few weeks. The patient's serum was found negative for HBsAg after 3 months. Immunohistochemical analysis of liver biopsies before and d…

MaleHepatitis B virusHBsAgAlpha interferonmedicine.disease_causeDrug DiscoverymedicineHumansViremiaSeroconversionGenetics (clinical)Interferon alfaHepatitis B virusAIDS-Related Opportunistic Infectionsbusiness.industryInterferon-alphaGeneral MedicineMiddle AgedHepatitis BHepatitis Bmedicine.diseaseChronic DiseaseImmunologyPrednisoloneMolecular MedicineViral diseasebusinessmedicine.drugThe Clinical Investigator
researchProduct

Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating vir…

1998

Abstract Background/Aims: Seroconversion to anti-HBs or the loss of HBsAg is usually associated with complete elimination of the replicative hepatitis B virus. Usually in these patients hepatitis B virus DNA (HBV DNA) becomes undetectable. Routine controls of patients who underwent anti-HBs seroconversion by more sensitive tests showed that in some cases the virus persisted in the patient. Therefore the aim of our study was to evaluate if virus persistence could also be found in children with chronic hepatitis B after anti-HBs seroconversion. The virus pool should be characterized before and after seroconversion. Methods: Viral DNA was extracted from nine HBsAg negative or anti-HBs positive…

MaleHepatitis B virusHBsAgHepatitis B virus DNA polymeraseMolecular Sequence Datamedicine.disease_causeVirusOrthohepadnavirusmedicineHumansAmino Acid SequenceHepatitis B AntibodiesSeroconversionChildHepatitis B virusHepatitis B Surface AntigensHepatologybiologyInfantvirus diseasesHepatitis BHepatitis Bbiology.organism_classificationmedicine.diseaseVirologydigestive system diseasesHepadnaviridaeChild PreschoolChronic DiseaseDNA ViralImmunologyFemaleJournal of Hepatology
researchProduct

Active hepatitis B vaccination of dialysis patients and medical staff

1984

AbstractActive hepatitis B vaccination of dialysis patients and medical staff. One hundred six patients with terminal renal insufficiency and 29 medical personnel were given three doses of hepatitis B vaccine at an interval of 0, 1, and 6 months (Merck, Sharp and Dohme, West Point, Pennsylvania, part of a joint study no. 649). Chronic hemodialysis patients (N = 99) received 40 µg vaccine (V) i.m. Uremic patients, who were just about to start chronic dialysis treatment (N = 7), were given 40 µg V, and at the first vaccination 3ml hyperimmune globulin (HBIG) in addition. The medical personnel was alternately vaccinated with 20 µg V (N = 8), 40 µg (N = 11), 40 µg V, and 3ml HBIG at the first v…

MaleHyperimmune globulinHepatitis B virusPediatricsmedicine.medical_specialtyHepatitis B vaccinemedicine.medical_treatmentAntibodies ViralRenal DialysisMedical Staff HospitalHumansMedicineHepatitis B VaccinesSeroconversionDialysisbiologybusiness.industryVaccinationImmunization PassiveViral VaccinesHepatitis BHepatitis Bmedicine.diseaseOccupational DiseasesVaccinationTiterImmunizationNephrologybiology.proteinKidney Failure ChronicFemalebusinessKidney International
researchProduct

Role and outcomes of laparoscopic cholecystectomy in the elderly.

2014

Abstract Introduction : Laparoscopic cholecystectomy is the standard of treatment for gallstones disease and acute colecystitis. The prevalence of this disease increases with age and the population is aging in industrialized countries. So, in this study we report our experience in the treatment of gallstone disease in elderly patients, particularly analyzing the outcomes of laparoscopic approach. Methods : Between January 2010 and May 2014 we performed a total of 1227 cholecystectomies. In this retrospective study age group was the primary independent variable: 351 patients were 65–79 years of age and 65 were 80 years of age or older. Results : Only 65 patients (5.3%) of all population had …

MaleLaparoscopic surgerymedicine.medical_specialtymedicine.medical_treatmentLaparoscopic cholecystectomy Gallstone disease-elderly Laparoscopy Laparoscopic surgery Geriatric surgeryCholecystitis AcutePopulationComorbidityGallstonesDiseaseLaparoscopic surgeryCohort StudiesLaparoscopic cholecystectomyCholelithiasismedicineGeriatric surgeryHumansCholecystectomyLaparoscopyeducationAgedRetrospective StudiesAged 80 and overeducation.field_of_studymedicine.diagnostic_testbusiness.industryGeneral surgeryRetrospective cohort studyGeneral MedicineGallstonesMiddle Agedmedicine.diseaseConversion to Open SurgeryComorbiditySettore MED/18 - Chirurgia GeneraleTreatment OutcomeCholecystectomy LaparoscopicElective Surgical ProceduresGallstone disease-elderlyFemaleLaparoscopySurgerybusinessDeveloped country
researchProduct

“Relaparoscopic” management of surgical complications: The experience of an Emergency Center

2015

Background/aim: Laparotomy has been the approach of choice for re-operations in patients with surgical complications. The aim of this retrospective analysis was to evaluate the feasibility and the safety of laparoscopic approach for the management of general abdominal surgery complications. Materials and methods: We report a retrospective review of 75 patients who underwent laparoscopic evaluation for postoperative complications over a 4-year period. Primary outcomes (resolution rate by exclusive laparoscopic approach, conversion rate, further surgery rate) and secondary outcomes (mortality, hospitalization, prolonged ileus, wounds problems and median operative time) were evaluated. Results…

MaleLaparoscopic surgery“Second-look” surgeryDelayed DiagnosisTime Factorsmedicine.medical_treatmentlaw.inventionCohort StudiesPostoperative Complications0302 clinical medicinelawLaparotomyMedicineLaparoscopyDigestive System Surgical ProceduresAged 80 and overmedicine.diagnostic_testMiddle AgedConversion to Open SurgeryIntensive care unitRelaproscopy; Surgical complications; “Redo” surgery; “Second-look” surgery; Surgery030220 oncology & carcinogenesisRelaproscopyFemale030211 gastroenterology & hepatologyAdultReoperationmedicine.medical_specialtyAbdominal AbscessAdolescentIleusOperative TimeYoung Adult03 medical and health sciencesIleusSurgical complication“Redo” surgeryAppendectomyHumansSurgical Wound InfectionCholecystectomyMortalityAgedRetrospective StudiesLaparotomybusiness.industryRetrospective cohort studyLength of Staymedicine.diseaseSurgerySettore MED/18 - Chirurgia GeneraleSecond-Look SurgeryLaparoscopySurgeryCholecystectomybusinessAbdominal surgerySurgical Endoscopy
researchProduct

Functional networks of motor inhibition in conversion disorder patients and feigning subjects

2016

The neural correlates of motor inhibition leading to paresis in conversion disorder are not well known. The key question is whether they are different of those of normal subjects feigning the symptoms. Thirteen conversion disorder patients with hemiparesis and twelve healthy controls were investigated using functional magnetic resonance tomography under conditions of passive motor stimulation of the paretic/feigned paretic and the non-paretic hand. Healthy controls were also investigated in a non-feigning condition. During passive movement of the affected right hand conversion disorder patients exhibited activations in the bilateral triangular part of the inferior frontal gyri (IFG), with a…

MaleMotor DisordersAudiologylcsh:RC346-4290302 clinical medicineddc:150Neural PathwaysImage Processing Computer-AssistedYoung adultPrefrontal cortexFeigningParesismedicine.diagnostic_test05 social sciencesfMRIRegular ArticleMiddle AgedMagnetic Resonance ImagingInhibition PsychologicalTreatment OutcomeNeurologyMotor inhibitionlcsh:R858-859.7Femalemedicine.symptomPsychologyAdultmedicine.medical_specialtyImagery PsychotherapyCognitive Neurosciencelcsh:Computer applications to medicine. Medical informatics050105 experimental psychologyFunctional networks03 medical and health sciencesYoung AdultmedicineHumans0501 psychology and cognitive sciencesRadiology Nuclear Medicine and imagingIn patientConversion disorderlcsh:Neurology. Diseases of the nervous systemMagnetic resonance imagingmedicine.diseaseOxygenHemiparesisConversion disorderMotor paresisNeurology (clinical)NeuroscienceConversion disorder ; Motor inhibition ; Feigning ; fMRI ; Motor paresis030217 neurology & neurosurgery
researchProduct